Seatrade Cruise News is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Swab tests for Costa passengers, RINA approves biosafety measures

RINA's Biosafety Trust Certificate recognises Costa's on board biological risk prevention system
COVID-19 tests will be required for all passengers travelling on board Costa Cruises’ ships when operations restart for the Italian market on September 6, amid the line obtaining RINA’s Biosafety Trust Certification.

Costa will perform the COVID-19 antigenic tests for embarking guests on Deliziosa and Diadema, which resume sailings next month, and any of its ships that may recommence operations in the future. 

Passengers will be offered insurance with specific services owing to COVID-19.


Biosafety certification from RINA results from Costa’s staff training on health and safety measures during embarkation and shore excursions, introduced as part of the Costa Safety Protocol developed by a team of independent experts. 

The certification process, carried out via audits, examines all aspects of life on board and ashore, including embarkation procedures, hotel services, catering, fitness, relaxation areas and shore excursions, and assesses compliance with preventing and controlling infections.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.